These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Correction of haemostatic defect in cyanotic congenital heart-disease. Green D Lancet; 1971 Aug; 2(7722):486-7. PubMed ID: 4105348 [No Abstract] [Full Text] [Related]
5. Epsilon-aminocaproic acid in preoperative correction of haemostatic defect in cyanotic congenital heart-disease. Gralnick HR Lancet; 1970 Jun; 1(7658):1204-5. PubMed ID: 4192381 [No Abstract] [Full Text] [Related]
6. Experimental disseminated intravascular coagulation effect of heparin and epsilon-aminocaproic acid on tests of hemostatic function. Minn SK; Mandel EE Thromb Res; 1975 Mar; 6(3):235-46. PubMed ID: 1114490 [No Abstract] [Full Text] [Related]
7. Blood coagulation and platelet abnormalities in cyanotic congenital heart-disease. Goldschmidt B Lancet; 1973 Mar; 1(7803):607. PubMed ID: 4120672 [No Abstract] [Full Text] [Related]
8. Coagulation in cyanotic congenital heart disease. Wedemeyer AL; Edson JR; Krivit W Am J Dis Child; 1972 Nov; 124(5):656-60. PubMed ID: 5085479 [No Abstract] [Full Text] [Related]
9. Consumption coagulopathy in a child with congenital cyanotic heart disease and its treatment with heparin. Patil AS; Sarup BM; Mehta S Indian J Pediatr; 1975 Jan; 42(324):17-21. PubMed ID: 1132902 [No Abstract] [Full Text] [Related]
10. Thrombosis and intravascular coagulation. Coe NP; Salzman EW Surg Clin North Am; 1976 Aug; 56(4):875-90. PubMed ID: 959952 [TBL] [Abstract][Full Text] [Related]